(MedTech Strategist) – J&J’s recent blockbuster deal for Auris is really just the latest in a series of moves the diversified market giant has made in positioning itself in the exploding field of robotically-enabled surgery. From Verb, its joint venture with Verily, to Orthotaxy to, now, Auris, J&J is developing and advancing what the company calls “a comprehensive digital surgery experience.” […]
(Motley Fool) – J&J’s latest acquisition might appear to threaten its partnership with Alphabet to develop robotic surgical systems. But another player could be affected even more. […]
Focused on creating the next frontier of surgery, Johnson & Johnson (NYSE: JNJ), today announced that Ethicon, Inc., entered into a definitive agreement to acquire Auris Health, Inc. for approximately $3.4 billion in cash. […]
(3Dnatives) – Johnson & Johnson-owned franchise, DePuy Synthes Ireland is investing €36 million to establish a 3D Printing Development and Launch Center in order to accelerate its additive manufacturing projects. […]
(Bloomberg) – Johnson & Johnson, the world’s largest maker of health-care products, is pursuing an acquisition of Auris Health Inc. in a deal that would bring it cutting-edge surgical robotics technology, people with knowledge of the matter said. […]
(Forbes) – The CEO of Alphabet and Johnson & Johnson’s robotic surgery startup, Verb Surgical, left the company a little more than three weeks ago, he confirmed to Forbes on Friday. Scott Huennekens had been CEO of the company since it was founded in 2015. […]
Copyright © 2019 | MH Magazine WordPress Theme by MH Themes